Lilley Ross, Wainwright Elaine, Forget Patrice
Gateshead Health NHS Foundation Trust, Queen Elizabeth Hospital, Gateshead NE9 6SX, UK.
Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
J Clin Med. 2024 Jan 25;13(3):686. doi: 10.3390/jcm13030686.
Chronic conditions, especially pain conditions, have a very significant impact on quality of life and on workplaces. Workplace interventions for chronic conditions are heterogenous, multidimensional, and sometimes poorly evidenced. The Joint Action for Chronic Disease Plus (CHRODIS Plus), including The CHRODIS Plus Workbox on Employment and Chronic Conditions (CPWEC), aimed to combat this, prevent chronic disease and multimorbidity, and influence policy in Europe. However, the supporting evidence behind CHRODIS Plus has not been formally assessed. A scoping review was carried out; Embase, MEDLINE, and CINAHL were searched for literature related to CHRODIS Plus and pain. Title and abstract and full-text screening were carried out in duplicate and independently. Additionally, CHRODIS Plus authors were approached for unpublished data. Secondly, the search was broadened to CHRODIS Plus and pain-causing conditions. Grey literature was also searched. Appropriateness appraisal was derived from the Trial Forge Guidance. Systematic reviews, on which CPWEC was based, were appraised using the A Measurement Tool to Assess systematic Reviews (AMSTAR) 2 tool. The initial search yielded two results, of which zero were suitable to be included in the scoping review. The second, broader search revealed 14 results; however, none were deemed suitable for inclusion. AMSTAR 2 scores revealed that the three systematic reviews influencing CPWEC were of varying quality (from critically low to moderate). CPWEC is based on heterogenous reviews of varying quality. However, comparable tools are designed using alternative forms of evidence. Further research evaluating the post-implementation efficacy of the tool is needed.
慢性病，尤其是疼痛性疾病，对生活质量和工作场所有着非常重大的影响。针对慢性病的工作场所干预措施具有异质性、多维度性，有时缺乏充分的证据支持。慢性病联合行动升级版（CHRODIS Plus），包括CHRODIS Plus就业与慢性病工作箱（CPWEC），旨在应对这一问题，预防慢性病和多种疾病并存，并影响欧洲的政策。然而，CHRODIS Plus背后的支持证据尚未得到正式评估。开展了一项范围综述；在Embase、MEDLINE和CINAHL数据库中搜索与CHRODIS Plus和疼痛相关的文献。标题、摘要和全文筛选由两人独立重复进行。此外，还联系了CHRODIS Plus的作者获取未发表的数据。其次，搜索范围扩大到CHRODIS Plus和疼痛性疾病。还搜索了灰色文献。适用性评估源自试验锻造指南。对CPWEC所基于的系统评价，使用评估系统评价的测量工具（AMSTAR）2工具进行评估。初步搜索产生了两个结果，其中没有一个适合纳入范围综述。第二次更广泛的搜索揭示了14个结果；然而，没有一个被认为适合纳入。AMSTAR 2评分显示，影响CPWEC的三项系统评价质量各不相同（从极低到中等）。CPWEC基于质量各异的异质性综述。然而，可比工具是使用其他形式的证据设计的。需要进一步研究评估该工具实施后的效果。
